Virtual conference will focus on COVID-19’s impact on companies and universities
INDIANAPOLIS, Ind., August 25, 2020 – BioCrossroads today announced speakers for the 2020 Virtual Indiana Life Sciences Summit on October 7. The Conference kicks off at 10:00 a.m. with remarks from global life sciences thought leaders on the topic of Indiana life sciences and healthcare community’s COVID-19 response.
Healthcare and life sciences industry speakers include:
- David Ricks, chairman and CEO, Eli Lilly and Company
- Rajeev Ronanki, chief digital officer, Anthem; Beth Keyser, president, Anthem Blue Cross Blue Shield of Indiana
- Matt Sause, president and CEO, Roche Diagnostics; Marcela Kirberger, general counsel and secretary, Roche Diagnostics
- Dr. Ram Yeleti, EVP, chief physician executive, Community Health Network
- Pete Yonkman, president, Cook Group; Dan Peterson, vice president of industry and government affairs, Cook Group
Speakers from Indiana’s research institutions will discuss the impact of COVID-19 on new and existing research, including Dr. Jay Hess, dean / executive vice president for University Clinical Affairs, Indiana University School of Medicine; Dr. Theresa Mayer, vice president of research, Purdue University; and Dr. Marie Lynn Miranda, provost, University of Notre Dame
In addition, a discussion with some of Indiana’s newest life sciences companies – Abbot, Novartis, Brickell Biotechnologies and Point Biopharma — will reveal why they chose the Hoosier state for their operations.
The annual Watanabe Life Sciences Champion of the Year will be awarded to an influential and innovative Hoosier, and winners of the BioCrossroads DataX Bio-Innovation Challenge will present findings to their experiments in the fields of diabetes and opioid addiction.
Presenting sponsors of the conference are Cook Medical and Eli Lilly and Company.
More information and registration are available www.biocrossroads.com.
BioCrossroads is Indiana’s initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region’s existing research and corporate strengths while encouraging new business development. BioCrossroads invests capital and provides support to life sciences businesses, launches new life sciences enterprises (Indiana Biosciences Research Institute, 16 Tech, Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, OrthoWorx and Datalys Center), expands collaboration and partnerships among Indiana’s life science institutions, promotes science education and markets Indiana’s life sciences industry.